Skip to main content Back to Top
Advertisement

9/29/2025

Succinylcholine Injection

Products Affected - Description

    • Succinylcholine Chloride injection, Accord, 20 mg/mL, 10 mL vial, 10 count, NDC 16729-0493-45 - discontinued
    • Succinylcholine Chloride injection, Amneal, 20 mg/mL, 10 mL vial, 10 count, NDC 70121-1581-05 - discontinued
    • Succinylcholine Chloride injection, Hikma, 20 mg/mL, 10 mL vial, 25 count, NDC 00143-9338-25
    • Succinylcholine Chloride injection, Hikma, 20 mg/mL, 5 mL syringe, 10 count, NDC 00641-6234-10
    • Succinylcholine Chloride injection, Nordic Pharma (formerly Amring), 20 mg/mL, 10 mL vial, 25 count, NDC 69918-0700-25
    • Succinylcholine Chloride injection, Piramal Critical Care, 20 mg/mL, 10 mL vial, 25 count, NDC 66794-0232-42
    • Succinylcholine Chloride injection, Sagent, 20 mg/mL, 10 mL vial, 10 count, NDC 25021-0677-10 - discontinued
    • Succinylcholine Chloride injection, Zydus, 20 mg/mL, 10 mL vial, 25 count, NDC 70710-1377-02

Reason for the Shortage

    • Accord has discontinued succinylcholine.
    • Amneal has discontinued succinylcholine.
    • Nordic Pharma (formerly Amring) did not provide a reason for the shortage.
    • Camber did not provide a reason for the shortage.
    • Devatis has succinylcholine injection available.
    • Fresenius Kabi has succinylcholine injection available.
    • Hikma did not provide a reason for the shortage.
    • Meitheal has succinylcholine injection available.
    • Piramal did not provide a reason for the shortage.
    • Sagent discontinued succinylcholine in 2024.
    • Somerset has succinylcholine injection available.
    • Zydus did not provide a reason for the shortage.
    • Pfizer has Quelicin injection available.
    • Sandoz has Anectine injection available.

Available Products

    • Anectine injection, Sandoz, 20 mg/mL, 10 mL vial, 10 count, NDC 00781-3119-95
    • Quelicin injection, Pfizer, 20 mg/mL, 10 mL vial, 25 count, NDC 00409-6629-02
    • Succinylcholine Chloride injection, Camber, 20 mg/mL, 10 mL vial, 25 count, NDC 31722-0981-31
    • Succinylcholine Chloride injection, Devatis, 20 mg/mL, 10 mL vial, 25 count, NDC 73043-0021-01
    • Succinylcholine Chloride injection, Fresenius Kabi, 20 mg/mL, 10 mL syringe, 10 count, NDC 65219-0276-10
    • Succinylcholine Chloride injection, Fresenius Kabi, 20 mg/mL, 10 mL vial, 25 count, NDC 63323-0943-10
    • Succinylcholine Chloride injection, Fresenius Kabi, 20 mg/mL, 5 mL syringe, 10 count, NDC 65219-0274-05
    • Succinylcholine Chloride injection, Meitheal Pharmaceuticals, 20 mg/mL, 10 mL vial, 25 count, NDC 71288-0719-11
    • Succinylcholine Chloride injection, Nordic Pharma (formerly Amring), 20 mg/mL, 10 mL vial, 10 count, NDC 69918-0700-12
    • Succinylcholine Chloride injection, Somerset Therapeutics LLC, 20 mg/mL, 10 mL vial, 10 count, NDC 70069-0301-10
    • Succinylcholine Chloride injection, Somerset Therapeutics LLC, 20 mg/mL, 10 mL vial, 25 count, NDC 70069-0301-25

Estimated Resupply Dates

    • Hikma has succinylcholine 20 mg/mL 10 mL vials on back order and the company estimates a release date of mid-October 2025. The 5 mL syringes are on back order and the company cannot estimate a release date.
    • Nordic Pharma (formlerly Amring) has succinylcholine 20 mg/mL 10 mL vials in 25 count on back order and the company cannot estimate a release date.
    • Piramal has succinylcholine 20 mg/mL 10 mL vials on allocation.
    • Zydus has short-dated succinylcholine 20 mg/mL 10 mL vials available with an expiration date of April 2026.

Updated

Updated September 29, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created February 21, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.

ADVERTISEMENT